baber/WOPTO huggingface dataset:
Patent NZ-578449-A (NZ)
Title: Power supply apparatus for a capacitive load including a third coil to determine zero crossings and a device to control the ac power delivered to the load
Inventor: HANSSON MIKAEL
IPC: C01B13/10
Filed: 2007-12-17
Abstract: Disclosed is a power supply apparatus (100) for supplying electric power to a capacitive load (300). The apparatus has a transformer (110), a positive half-period driver and a negative half-period driver supplying positive and negative half-periods of voltage to a first coil (120) of the transformer. A second coil (130) of the transformer forms an electric resonance circuit and supplies electric voltage to the load. Zero crossings of the voltage supplied to the first coil are determined from a third coil on the transformer, and alternation between positive and negative half-periods of voltage supplied to the first coil is done at the zero crossings of the voltage supplied to the first coil. The apparatus also includes a device to control the power delivered to the load by controlling the duration of the voltage fed to a center tap (121) of the first coil.
Patent NZ-583999-A (NZ)
Title: Liquid formulation comprising g-csf, sugar alcohol, surfactant and an acetate
Inventor: HINDERER WALTER
IPC: A61P7/00
Filed: 2008-08-27
Abstract: Medicament comprising an aqueous liquid formulation of Granulocyte-Colony Stimulating Factor (G-CSF), substantially consisting of G-CSF and a sugar alcohol, a surfactant at a concentration of 0.05 to 0.06 mg/ml, acetate at a concentration of 5 to 20 mM as a buffer substance at a pH value of 4.15 to 4.3, and optionally amino acids and/or glycerol and/or carbohydrates and/or preservatives. The formulation has the advantage of being better tolerated by patients.
Patent NZ-589530-A (NZ)
Title: Brake system for wind turbine with rotor lock having outer rotor having recesses and inner stator having piston to engage in recesses
Inventor: ERIKSEN UFFE
IPC: F03D11/00
Filed: 2010-11-25
Abstract: A rotor lock is integrated into the brake system which has a rotor assembly and a stator assembly. The rotor assembly has a brake disc having a radially inner surface having recesses 15. The stator assembly has at least one piston 16 which is located so that it is prepared to engage with the recesses 15.
Patent NZ-590054-A (NZ)
Title: Compositions and uses of fingolimod (2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol)
Inventor: KOVARIK JOHN M
IPC: A61K31/133
Filed: 2005-11-28
Abstract: Disclosed is the use of a compound which is 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol (FTY720 / fingolimod) in free form or in a pharmaceutically acceptable salt form (such as the hydrochloride), for the preparation of a medicament for treating an autoimmune disease (such as multiple sclerosis, lupus nephritis, rheumatoid arthritis, inflammatory bowel diseases and psoriasis) in a patient in need thereof, whereby said medicament is adapted for administration of a daily oral dosage of 0.5 mg.
Patent NZ-593198-A (NZ)
Title: Process for preparing hydrocodone comprising a super acid-assisted furan ring closure reaction
Inventor: WANG PETER X
IPC: C07D489/02
Filed: 2009-11-30
Abstract: Disclosed is a process for converting a fused, tricyclic compound (Formula (I)) to a fused, tetracyclic compound that includes a furan ring (Formula (II)). Further disclosed is a process for preparing a hydrocodone compound, or a compound structurally related thereto, in particular (+)-hydrocodone, by subjecting a structurally corresponding sinomenine (cocculine) starting compound to a super acid-assisted furan ring closure reaction.
Patent NZ-594556-A (NZ)
Title: Carboxamide compounds and methods for using the same
Inventor: SINGH RAJINDER
IPC: A61K31/501
Filed: 2010-01-28
Abstract: 594556 Disclosed herein are carboxamide compounds, pharmaceutical compositions comprising said compounds and the use of said compounds in the treatment of metabolism-related disorders and conditions, such as those mediated by activating the AMPK pathway in a cell. Embodiments of the compounds include the following: 5-(4-(4-cyanobenzyl)piperazine-1-carbonyl)-N-(1-(4-cyanobenzyl)piperidin-4-yl)picolinamide, and (S)-5-(4-(4-chlorophenyl)piperazine-1-carbonyl)-N-(1-(4-fluorobenzyl)pyrrolidin-3-yl)picolinamide.
Patent NZ-601819-A (NZ)
Title: System and method of event sequencing and record automation for healthcare
Inventor: DARLING MATTHEW ROSS
IPC: G16H10/60
Filed: 2011-02-15
Abstract: 601819 Disclosed is a method for healthcare action sequencing by a bedside device. A patient care area is scanned for tags for entities present in the area such that a given patient is located in the area. In response to detecting a tag for an entity in the area, identity data is read from the tag. Input data (16, 17) is received regarding the given patient by at least one healthcare personnel via a user-interface which is then sent with the input data (16, 17) to a management system that includes a first database storing first rules for how patients with known sets of conditions are to be cared for, a second database (11) storing second rules for how the input data (16, 17) are to be used, and a third database (13) storing third rules relating to procedures and restrictions for the at least one healthcare personnel. Action data is then received for the given patient from the management system based at least in part on the identity data, the input data (16, 17), and at least one of the first rules, the second rules, and the third rules. Information is then displayed on the user-interface based at least in on the received action data.
Patent NZ-602144-A (NZ)
Title: Novel glyphosate formulation
Inventor: MAHARAJ ABHINETIRI
IPC: A01N57/02
Filed: 2010-12-08
Abstract: 602144 Disclosed herein is a solid glyphosate formulation comprising glyphosate acid and further comprising at least one agriculturally acceptable salt of glyphosate, wherein the glyphosate acid and the at least one glyphosate salt are in admixture and wherein the mole ratio of glyphosate acid to total glyphosate moieties in the formulation is at least 10% and less than 50%. Specifically wherein the formulation consists of granules, more specifically wherein the granule are in the range of 0.5 mm to 3 mm in length. Additionally wherein the formulation comprises one or more adjuvants, specifically wherein the adjuvant comprises a glyphosate synergising surfactant, such as cocobetaine, cocoaminopropylbetaine, tallowamine-15-ethoxylate, alkylglycosides, and alkylamine alkoxylates. Specifically wherein the glyphosate salt comprises cations chosen from the group consisting of ammonium, sodium, potassium ethanolammonium, diethanolammoniu,, triethanolammonium, propylammonium, isoproylammonium and trimesium cations. Additionally a method of removing unwanted foliage comprising administering a diluted form of said solid glyphosate formulation.
Patent NZ-614472-A (NZ)
Title: Systems and methods for ex-vivo organ care
Inventor: HASSANEIN WALEED
IPC: A01N1/02
Filed: 2005-10-07
Abstract: A single use module for a heart preservation system is disclosed. The single use module comprises a chassis, a perfusion circuit for circulating perfusion fluid, and an organ chamber assembly (160) mounted to the chassis for containing a heart. The organ chamber assembly (160) includes at least two conduits (162, 170, 166) for connecting the perfusion circuit to the heart. The module also includes pump interface (see Fig. 8A) with a tapered projection for interlocking with a bracket of the preservation system.
Patent NZ-619627-A (NZ)
Title: Textile mask systems
Inventor: DUNN JESSICA LEA
IPC: A61M16/06
Filed: 2012-07-12
Abstract: A mask system for delivering pressurized breathable gas to a patient, comprising: a chamber forming portion including: a front panel (30) and a back panel (20) at least partially delimiting a cavity adapted to receive a nose of a patient, the back panel including an opening formed therein through which the patient’s nose is received into the cavity; and a seal member (40) formed as part of or coupled to at least one of the front or back panel and adapted to sealingly engage the patient’s face. At least one of the front or the back panel comprises a textile and the seal member comprises a polymer. A rigidizer frame is coupled to the chamber forming portion to provide structural support thereto.
Patent NZ-624040-A (NZ)
Title: 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
Inventor: TOURE BAKARY-BARRY
IPC: C07D513/04
Filed: 2012-09-26
Abstract: Disclosed are 3-pyrimidin-4-yl-oxazolidin-2-one compounds of formula (I) or a pharmaceutically acceptable salt thereof, wherein R1-R6 are defined in the specification. Also disclosed are compositions containing a compound of formula (I) and to the use of such compounds in the inhibition of mutant IDH proteins having a neomorphic activity. Further disclosed is the use of a compound of formula (I) in the treatment of diseases or disorders associated with such mutant IDH proteins including, but not limited to, cell-proliferation disorders, such as cancer.
Patent NZ-625178-A (NZ)
Title: A method of characterising the structure of a void sensitized explosive composition
Inventor: COOPER JOHN
IPC: G01N33/22
Filed: 2012-12-13
Abstract: A method of characterising the structure of a void sensitized liquid energetic material comprises defining the material in terms of a distribution function. The distribution function represents the fraction of liquid energetic material that occurs at a given distance from any void surface within the void sensitized liquid energetic material. A method of achieving a designed bulk detonation energy output in an explosives material comprises sensitizing voids distributed within a liquid energetic material. The method comprises determining a distribution function template that is representative of the designed detonation energy output for the explosives material and formulating an explosive material consistent with that distribution function template by suitable placement and distribution of sensitizing voids within a liquid energetic material. Also disclosed is the explosive material produced by this method. A explosive material comprises sensitizing voids distributed in a liquid energetic material. The explosive composition exhibits a plot of distribution function rate versus distribution function that includes a point of inflexion.
Patent NZ-625668-A (NZ)
Title: A method for monitoring the operation of a liquid food processing system
Inventor: SVENSSON CECILIA
IPC: B08B9/032
Filed: 2012-12-14
Abstract: Disclosed is a liquid food processing system. The system comprises at least one section (110, 120) through which liquid food products are flowing during food processing and causing build-up of deposits within the section (110, 120). The system also comprises at least one sensor (112, 114, 122, 124) configured to determine a pressure difference across the at least one section for monitoring removal or build-up of the deposits.
Patent NZ-629296-A (NZ)
Title: Humanized antibodies that recognize alpha-synuclein
Inventor: SALDANHA JOSE
IPC: C12P21/08
Filed: 2013-01-25
Abstract: Disclosed is an antibody comprising a mature heavy chain variable region comprising the three Kabat CDRs of SEQ ID NO:44 (namely SYYIH, WIYPGSGNTKYSEKFKG and DGXYGFAY, wherein X may be C, M, S or T), and being at least 90% identical to SEQ ID NO:44, and a light chain comprising the three Kabat CDRs of SEQ ID NO:45 (namely KASQSVDYDGDSYMN, AASNLES and QQSNEDPFT), and being at least 90% identical to SEQ ID NO:45, wherein SEQ ID NOs: 44 and 45 are disclosed within the specification.
Patent NZ-708324-A (NZ)
Title: Wireless charging system
Inventor: RAKOCZY STEVE
IPC: H02J50/90
Filed: 2013-11-27
Abstract: Known wireless charging systems can take up large areas. There is a need to provide a system which enables substantially identical devices to be charged efficiently. A system comprising a plurality of electronic devices, each comprising a device housing and a rechargeable battery, and a charger comprising a charger housing and arranged for charging said rechargeable batteries, wherein said charger comprises at least one, preferably a plurality, of wireless power transmitting coils in said housing and said electronic devices each comprise a wireless power receiving coil in said housing, wherein said power transmitting coils are arranged in an array along a pillar, and wherein said charger housing and said device housings are formed such that the power receiving coils of said electronic devices can be placed and held in an array along said pillar by placing said electronic devices in an array against each other, such that each power receiving coil has a corresponding power transmitting coil in its vicinity.
Patent NZ-722904-A (NZ)
Title: Multi-focal display system and method
Inventor: CHENG HUI-CHUAN
IPC: G02B30/52
Filed: 2015-01-30
Abstract: Configurations are disclosed for presenting virtual reality and augmented reality experiences to users. The system may comprise an image generating processor to providing one or more frames of image data, a light modulator to transmit light associated with the one or more frames of image data, a plurality of switchable screens having a range of numerical apertures to vary an effective numerical aperture associated with the one or more frames of image data, and a variable focus element (VFE) to vary a focus of the one or more frames of image data on one of the switchable screens of the plurality of switchable screens.
Patent NZ-723817-A (NZ)
Title: Cyclopropylamines as lsd1 inhibitors
Inventor: WU LIANGXING
IPC: C07D205/04
Filed: 2015-02-12
Abstract: The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.
Patent NZ-739429-A (NZ)
Title: Liquid pharmaceutical compositions comprising sglt-2 inhibitors
Inventor: WEILER CLAUDIUS
IPC: A61K31/7034
Filed: 2016-08-24
Abstract: The invention relates to novel liquid pharmaceutical compositions comprising at least one SGLT-2 inhibitor and one or more polar organic solvents selected from ethanol, propylene glycol and glycerol, wherein the at least one SGLT-2 inhibitor comprises 1-cyano-2-(4- cyclopropyl-benzyl)-4-(β-D-glucopyranos-1-yl)-benzene according to formula (I). The composition as a whole has a negative logP-parameter ≥ -2.0. The invention also relates to corresponding processes of manufacturing such liquid pharmaceutical compositions and their medical use for the treatment of metabolic disorders of equine, feline or canine animals.
Patent NZ-742150-A (NZ)
Title: Positioning and stabilising structure for a patient interface system
Inventor: DUNN JESSICA
IPC: A61M16/06
Filed: 2013-11-15
Abstract: A patient interface system (3000) to treat sleep disordered breathing of a patient with pressurized gas, comprising a patient interface (3301); a strap (3308); a retractor (3304) fixedly attached to the patient interface, the retractor connected to the strap and configured to retract both ends of the strap without patient actuation; a patient interface channel (3324) fixedly attached to the patient interface; and a cushion (3310) structured to at least partially conform to the patient’s head, the cushion having a pair of cushion channels (3322). The strap passes freely through each of the cushion channels and the patient interface channel such that upper portions of the strap pass above the patient’s ears and below the patient’s eyes when donned by the patient and lower portions of the strap pass below the patient’s ears when donned by the patient.
Patent NZ-760654-A (NZ)
Title: Compositions comprising a bacterial strain of the genus megaspahera and uses thereof
Inventor: MULDER Imke Elisabeth
IPC: A61K35/74
Filed: 2018-06-14
Abstract: The invention provides compositions comprising bacterial strains, in particular Megasphaera massiliensis (strain NCIMB 42787) for treating and preventing a neurodegenerative disorder or brain injury. Neurodegenerative disorders to be treated include Parkinson’s disease, including progressive supranuclear palsy, progressive supranuclear palsy, Steele-Richardson-Olszewski syndrome, normal pressure hydrocephalus, vascular or arteriosclerotic parkinsonism and drug-induced parkinsonism; Alzheimer’s disease, including Benson’s syndrome; Huntington’s disease; amyotrophic lateral sclerosis; Lou Gehrig’s disease; motor neurone disease; prion disease; spinocerebellar ataxia; spinal muscular atrophy; dementia, including Lewy body, vascular and frontotemporal dementia; primary progressive aphasia; mild cognitive impairment; HIV-related cognitive impairment and corticobasal degeneration. Brain injuries to be treated include stroke, such as cerebral ischemia, focal cerebral ischemia, ischemic stroke or hemorrhagic stroke.
Patent PT-100161-A (PT)
Inventor: GODEK DENNIS MICHAEL
IPC: C07D401/06
Filed: 1992-02-25
Abstract: (C1-C3)Alkyl-4,6,7,8,9,9a-hexahydro-2H,3H-pyrido-[1,2-a]pyrazin-1-one- 7-carboxylate esters, important precursors to certain bis-aza-bicyclic anxiolytics, can be prepared from di(C1-C3)alkyl cis-piperidine-2,5-dicarboxylate starting material by a new process via a new class of intermediates, di(C1-C3)alkyl cis-N-(2-(phthalimido)ethyl)piperidine-2,5-dicarboxylates. In the process, the starting material is reacted with either 2-(phthalimido)ethyl triflate or 2-(phthalimido)acetaldehyde to form the new intermediate, which can then be cyclized to the aforementioned precursor.
Patent RU-94001477-A (RU)
Inventor: MALAFEEV S I
IPC: H02P7/06
Filed: 1994-01-17
Abstract: FIELD: electric automatics. SUBSTANCE: method comes to control of operating mode of motor with subordinate regulation of current with its limiting. Current limiting is regulated depending on value of deviation of supply voltage from nominal value. Value of current limiting decreased at decrease in supply voltage makes it possible to decrease voltage drop in mains and deflections and fluctuations of voltage across terminals of electric consumers. EFFECT: provision of electromagnetic compatibility of equipment in power supply system characterized by commensurable power values in supply circuit and load. 3 dwg
Patent RU-94008771-A (RU)
Inventor: KSHIVETS O M
IPC: G01N33/50
Filed: 1994-03-14
Abstract: FIELD: medicine, specifically oncology. SUBSTANCE: invention can be used for adjuvant methods of therapy of patients with unfavorable prediction. Weight of patient, diameter of tumor, values of general and biochemical blood tests are used in the capacity of oncological indices and life expectancy of patient is predicted in days. EFFECT: improved authenticity of method.
Patent RU-94013391-A (RU)
Inventor: TOKAREV V V
IPC: C02F1/56
Filed: 1994-04-18
Abstract: FIELD: oil-refining, petrochemical and other industries. SUBSTANCE: before sewage purification beginning surface active substances and iron chloride (III) are fed into sewage in amount of 3 - 7 mg/l and 1-3 mg/l correspondingly. "Flokaton 200-40" or "KF-91" are used as surface active substances. EFFECT: method allows to increase degree of sewage purification from excessive active sludge (water clarification degree increased) and to decrease residual concentration of petroleum products in purified water.
Patent RU-94023744-A (RU)
Inventor: KONONOV V P
IPC: B60D1/14
Filed: 1994-06-23
Abstract: FIELD: car TOWING. SUBSTANCE: device includes cylindrical rigid pull members 1, 2, 3 interconnected through threaded rods and sleeves. Free ends of terminal pull members 1, 2 are provided with gripping devices in the form of hook 6 or in the form of threaded rod with spiral ends. EFFECT: car towing. 3 cl, 7 dwg
Patent RU-94025393-A (RU)
Inventor: TOMASHEVSKIJ L P
IPC: E21C41/18
Filed: 1994-07-05
Abstract: FIELD: mining industry. SUBSTANCE: through blast holes are drilled between headings driven in coal mass of sublevel. Holes are drilled in planes parallel to axis of degassing-compensation working. Holes positioned in two adjacent planes are so drilled between headings that their projections on to plane parallel to axis of degassing-compensation working cross. EFFECT: improved efficiency of process. 3 dwg
Patent RU-94025822-A (RU)
Inventor: ZAJDENBERG A Z
IPC: C02F1/28
Filed: 1994-07-12
Abstract: FIELD: sewage purification from oil products by filtration through carbon-bearing sorbent, power industry, metallurgy, chemical industry. SUBSTANCE: sewage is filtered through loading, that has mixture of schungite with wastes of schungizite production with following ratio of components, volumetric %: schungite 92-99; wastes of schunzite production 1-8. EFFECT: simplified process. 1 cl, 1 tbl
Patent RU-94026034-A (RU)
Inventor: EGER V S
IPC: B64C27/46
Filed: 1994-07-13
Abstract: FIELD: manufacture of aerodynamic and hydrodynamic streamlined articles. SUBSTANCE: solid sections of aerodynamic streamlined objects (load-bearing members) are formed. To this end, inner load-bearing layer is formed by spiral winding of fiber pregreg on mandrel. Then interlayer filler is placed at part of formed inner load-bearing layer and outer layer is formed by spiral winding of fiber pregreg on inner load-bearing layer formed before, after which interlayer filler is placed. Then row of solid sections of aerodynamic streamlined article which are load-bearing members which bear secondary load is formed. Row of sections thus formed carry main and secondary loads is arranged in definite sequence for forming aerodynamic streamlined article. Then, at least one layer of fiber pregreg is spirally wound on aerodynamic streamlined article thus formed which is subjected to polymerization at high temperature. Then mandrels are removed. EFFECT: enhanced reliability. 9 cl, 9 dwg
Patent RU-94026901-A (RU)
Inventor: KORE BREJVIK
IPC: B67D/
Filed: 1992-03-30
Abstract: FIELD: shipbuilding. SUBSTANCE: system is used for making ship 1 fast to buoy 2 anchored at sea bottom. Buoy is received by intake chamber 3 provided in ship 1 where it is secured. In course of operation buoy 2 is connected to at least one service pipe line 4 and forms joints between this pipe line and shipboard system 1. Buoy 2 has outer member for rigid attachment in intake chamber 3 and central inner member mounted rotatably on outer member, thus enabling the ship to turn about central member when buoy 2 is secured in intake chamber 3. Besides that, upper end of central member is connected to shipboard pipe line through hinge and through at least one movable joint. EFFECT: enhanced reliability.
Patent RU-94027313-A (RU)
Inventor: GIZATULLIN S A
IPC: B05B7/20
Filed: 1994-07-18
Abstract: FIELD: plasma process. SUBSTANCE: method of arc discharge (discharges) drawing provides for feeding of combustible gas mixture, spark break-down of interelectrode interval between main and auxiliary electrodes, that causes inflammation of combustible gas mixture, after which arc discharge is drawn between main electrodes and incombustible plasma-forming gasses are fed into interelectrode cavity. EFFECT: method of arc discharge drawing allows to draw electrical arc in plasmatrons with any distances between electrodes.